Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Are your patients at risk? Fungal contamination of Ilex paraguariensis St. Hil (yerba maté).

Di Pentima MC, Steele-Moore L, Muehlbauer L, Klein JD.

Transpl Infect Dis. 2005 Mar;7(1):47-8. No abstract available.

PMID:
15984951
2.

Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.

Vazquez JA, Peng G, Sobel JD, Steele-Moore L, Schuman P, Holloway W, Neaton JD.

Clin Infect Dis. 2001 Oct 1;33(7):1069-75. Epub 2001 Sep 5.

PMID:
11528582
3.

Molecular diversity of live-attenuated prototypic vaccine strains and clinical isolates of Staphylococcus aureus.

Buzzola FR, Quelle LS, Steele-Moore L, Berg D, Denamiel G, Gentilini E, Sordelli DO.

FEMS Microbiol Lett. 2001 Aug 7;202(1):91-5.

4.

Genotypic analysis of Staphylococcus aureus from milk of dairy cows with mastitis in Argentina.

Buzzola FR, Quelle L, Gomez MI, Catalano M, Steele-Moore L, Berg D, Gentilini E, Denamiel G, Sordelli DO.

Epidemiol Infect. 2001 Jun;126(3):445-52.

5.

Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.

Wong-Beringera A, Hindler J, Brankovic L, Muehlbauer L, Steele-Moore L.

Diagn Microbiol Infect Dis. 2001 Jan;39(1):25-31.

PMID:
11173188
6.

Correlation of fluconazole MICs with clinical outcome in cryptococcal infection.

Aller AI, Martin-Mazuelos E, Lozano F, Gomez-Mateos J, Steele-Moore L, Holloway WJ, Gutiérrez MJ, Recio FJ, Espinel-Ingroff A.

Antimicrob Agents Chemother. 2000 Jun;44(6):1544-8.

7.

Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses.

Sordelli DO, Buzzola FR, Gomez MI, Steele-Moore L, Berg D, Gentilini E, Catalano M, Reitz AJ, Tollersrud T, Denamiel G, Jeric P, Lee JC.

J Clin Microbiol. 2000 Feb;38(2):846-50.

10.

In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare.

Steele-Moore L, Stark K, Holloway WJ.

Antimicrob Agents Chemother. 1999 Jun;43(6):1530. No abstract available.

11.

In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.

Schwalbe RS, McIntosh AC, Qaiyumi S, Johnson JA, Johnson RJ, Furness KM, Holloway WJ, Steele-Moore L.

Antimicrob Agents Chemother. 1996 Oct;40(10):2416-9.

12.

Molecular karyotyping of multiple yeast species isolated from nine patients with AIDS during prolonged fluconazole therapy.

Espinel-Ingroff A, Quart A, Steele-Moore L, Metcheva I, Buck GA, Bruzzese VL, Reich D.

J Med Vet Mycol. 1996 Mar-Apr;34(2):111-6.

PMID:
8732356
13.

Ventriculoperitoneal shunt infection due to Listeria monocytogenes.

Winslow DL, Steele-Moore L.

Clin Infect Dis. 1995 May;20(5):1437. No abstract available.

PMID:
7677902
14.

Comparison of fluconazole minimum inhibitory concentrations in three different formulations of RPMI-1640.

Espinel-Ingroff A, Steele-Moore L.

Diagn Microbiol Infect Dis. 1994 Oct;20(2):87-91.

PMID:
7867310
15.

Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories.

Espinel-Ingroff A, Steele-Moore L, Galgiani JN.

Diagn Microbiol Infect Dis. 1994 Oct;20(2):81-6.

PMID:
7867309
16.

Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.

Pfaller MA, Vu Q, Lancaster M, Espinel-Ingroff A, Fothergill A, Grant C, McGinnis MR, Pasarell L, Rinaldi MG, Steele-Moore L.

J Clin Microbiol. 1994 Jul;32(7):1625-8.

Supplemental Content

Loading ...
Support Center